ROCK SPRINGS CAPITAL MANAGEMENT, LP

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Inozyme Pharma, Inc.
INZY
$28.2M5.953.68M0%+$00.73
Mereo BioPharma Group plc
MREO
$26.87M5.338.14M+1.98%+$522,251.410.7
Immunocore Holdings plc
IMCR
$153.91M4.742.37M-11.04%-$19.09M4.01
Travere Therapeutics, Inc.
TVTX
$26.41M4.53.42M+23.57%+$5.04M0.69
Accolade, Inc.
ACCD
$37.1M4.493.54M+1.58%+$576,400.000.97
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.